These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34079088)

  • 41. Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity.
    Todorovic V; Groselj B; Cemazar M; Prevc A; Zakelj MN; Strojan P; Sersa G
    Radiol Oncol; 2022 Apr; 56(2):173-184. PubMed ID: 35390246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.
    Cokelaere C; Dok R; Cortesi EE; Zhao P; Sablina A; Nuyts S; Derua R; Janssens V
    Cell Oncol (Dordr); 2024 Jun; 47(3):793-818. PubMed ID: 37971644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSRP2 promotes cell stemness in head and neck squamous cell carcinoma.
    Zhang MJ; Liu J; Wan SC; Li JX; Wang S; Fidele NB; Huang CF; Sun ZJ
    Head Neck; 2023 Sep; 45(9):2161-2172. PubMed ID: 37466293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas.
    Wu J; Mu Q; Thiviyanathan V; Annapragada A; Vigneswaran N
    Int J Oncol; 2014 Dec; 45(6):2365-72. PubMed ID: 25340704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
    Naz S; Leiker AJ; Choudhuri R; Preston O; Sowers AL; Gohain S; Gamson J; Mathias A; Van Waes C; Cook JA; Mitchell JB
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1295-1305. PubMed ID: 33838214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.
    Dickreuter E; Eke I; Krause M; Borgmann K; van Vugt MA; Cordes N
    Oncogene; 2016 Mar; 35(11):1353-62. PubMed ID: 26073085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
    Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
    Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
    Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
    Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
    [No Abstract]   [Full Text] [Related]  

  • 53. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.
    Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A
    Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma.
    Ye Z; Xiao M; Zhang Y; Zheng A; Zhang D; Chen J; Du F; Zhao Y; Wu X; Li M; Chen Y; Deng S; Shen J; Zhang X; Wen Q; Zhang J; Xiao Z
    Sci Rep; 2024 Jul; 14(1):15962. PubMed ID: 38987626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer.
    Liu X; Kumar M; Yang L; Molkentine DP; Valdecanas D; Yu S; Meyn RE; Heymach JV; Skinner HD
    Clin Cancer Res; 2018 Feb; 24(3):600-607. PubMed ID: 29113987
    [No Abstract]   [Full Text] [Related]  

  • 56. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
    Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
    Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
    Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
    [No Abstract]   [Full Text] [Related]  

  • 58. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response.
    Wurster S; Hennes F; Parplys AC; Seelbach JI; Mansour WY; Zielinski A; Petersen C; Clauditz TS; Münscher A; Friedl AA; Borgmann K
    Oncotarget; 2016 Mar; 7(9):9732-41. PubMed ID: 26799421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
    Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
    Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.